TREATMENT WITH DAILY SUBCUTANEOUS TERIPARATIDE (1-34) COMPARED WITH DAILY SUBCUTANEOUS PARATHYROID HORMONE (1-84) IN WOMEN WITH SEVERE POSTMENOPAUSAL OSTEOPOROSIS: A RANDOMIZED, HEAD-TO-HEAD STUDY

Research output: Contribution to conferenceOther

Original languageEnglish
PagesS48-S48
Number of pages1
Publication statusPublished - 2008

Cite this